Knudsen L, Hasenkam J M, Kure H H, Hughes P, Bellaiche L, Ahlburg P, Djurhuus C
Dept. of Clinical Immunology, Skejby Sygehus, Aarhus University Hospital, Denmark.
Thromb Res. 1996 Oct 1;84(1):45-54. doi: 10.1016/0049-3848(96)00160-0.
Despite high plasma levels of heparin during cardiopulmonary bypass surgery, activation of the coagulation system has been reported. We hypothesize that the coagulation system activity most appropriately could be assessed by molecular markers of thrombin generation. The aim of the present study was to describe the changes in thrombin generation during CPB, using prothrombin fragment F1 + 2 (F1.2) as an indicator and evaluate different blood sampling regimens for interpretation of the F1.2 measurements. Twenty patients, operated under extracorporeal circulation with coronary artery bypass grafting (CABG), comprised the study material. The heparin levels were maintained above 2.5 IU/ml throughout the bypass procedure and the functional AT-III level was kept above 0.5 U/ml. Despite of this anticipated inactivation of the coagulation system, the concentrations of F1.2 and FpA increased throughout CPB, particularly after release of the aortic crossclamp. F1.2 and FpA correlated significantly (R = 0.69). No statistically significant correlation was found between F1.2 formation rate and age, bodyweight, baseline ACT, ACT after 200 IU heparin/kg, average heparin concentration during CPB or average AT-III level during CPB.
Thrombin formation seems to be a continuous process during CPB despite adequate heparinization. The pattern of thrombin generation can be assessed most appropriately in terms of F1.2 generation rate. Extraordinary high levels of F1.2 were seen after release of the aortic crossclamp, indicating that the periods before and after aortic crossclamping should be evaluated separately.
尽管在心肺转流手术期间血浆肝素水平很高,但仍有报道称凝血系统被激活。我们假设凝血系统活性最适宜通过凝血酶生成的分子标志物来评估。本研究的目的是使用凝血酶原片段F1 + 2(F1.2)作为指标描述心肺转流期间凝血酶生成的变化,并评估不同的采血方案以解释F1.2测量结果。20例接受体外循环冠状动脉搭桥术(CABG)的患者构成了研究材料。在整个转流过程中,肝素水平维持在2.5 IU/ml以上,功能性抗凝血酶III(AT-III)水平保持在0.5 U/ml以上。尽管预期凝血系统会失活,但在整个心肺转流期间,F1.2和纤维蛋白肽A(FpA)的浓度均升高,尤其是在松开主动脉阻断钳后。F1.2和FpA显著相关(R = 0.69)。未发现F1.2生成率与年龄、体重、基线活化凝血时间(ACT)、200 IU肝素/kg后的ACT、心肺转流期间的平均肝素浓度或心肺转流期间的平均AT-III水平之间存在统计学显著相关性。
尽管肝素化充分,但在心肺转流期间凝血酶形成似乎是一个持续的过程。凝血酶生成模式最适宜根据F1.2生成率进行评估。在松开主动脉阻断钳后观察到F1.2水平异常升高,表明主动脉阻断前后的时期应分别评估。